Tripos
For more than a quarter of a century, Tripos, has been pioneering breakthroughs in aiding drug discovery through its proprietary informatics and research technologies. Tripos focuses on integrating leading-edge technology and innovative science to deliver consistently superior research products and services for the biotechnology, pharmaceutical, and other life science enterprises. The company partners with life science enterprises worldwide to accelerate and improve the creation of life-enhancing products, and offers:
- Software solutions designed for the expert user and the bench chemist
- Customized software development
- Compound libraries
- Joint chemistry research for lead identification and optimization.
Tripos, headquartered in St. Louis, Missouri, has large-scale research operations in the United Kingdom. Tripos Discovery Research Ltd., a subsidiary of Tripos, Inc., was founded in 1997 and is based in Bude, England. This state-of-the-art laboratory facilitates Tripos' compound discovery collaborations and provides a unique atmosphere where over 170 scientists and researchers directly apply their expertise in the areas of molecular informatics, design and analysis. Tripos' global client base consists of more than 1,000 customers spanning over 46 countries.
SYBYL Software Suite
SYBYL© is a suite of computational informatics software designed to enhance the drug discovery workflows and decision-making of today's computational chemists and molecular modelers. » more
Benchware Software Suite
Benchware® is a unique suite of laboratory informatics software specifically designed to meet the challenging demands placed on today's laboratory chemists. » more
Discovery Informatics
Discovery Research
Tripos' Scientific Weblog
- Time for Something New - Topomer CoMFA and Topomer Search
- QSAR Reborn in Boston: An ACS Symposium in Memory of Dr. Phillip Magee
- Invest ten minutes to obtain 3D-QSAR based structure/activity insight and predictions!
- Could ignoring octanol/water LogP correlation impact the overall effectiveness of pharmaceutical discovery?
- Generalizations in Docking Calculations
- What?s a Drug Designer To Do?
- Strain Energy: Who Cares?

